Principal Financial Group Inc Alaunos Therapeutics, Inc. Transaction History

Principal Financial Group Inc

$172 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.41 - $1.24 $25,734 - $77,829	-62,766 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$0.62 - $1.17 $802 - $1,513	1,294 Added 2.11%	62,766 $41,000
Q4 2021 Feb 09, 2022	SELL	$1.09 - $1.89 $29,043 - $50,359	-26,645 Reduced 30.24%	61,472 $67,000
Q3 2021 Nov 09, 2021	BUY	$1.44 - $2.73 $7,392 - $14,015	5,134 Added 6.19%	88,117 $160,000
Q2 2021 Aug 10, 2021	SELL	$2.63 - $3.67 $7,411 - $10,342	-2,818 Reduced 3.28%	82,983 $219,000
Q1 2021 May 10, 2021	BUY	$2.82 - $5.6 $2,535 - $5,034	899 Added 1.06%	85,801 $309,000
Q4 2020 Feb 08, 2021	BUY	$2.09 - $3.09 $42,487 - $62,816	20,329 Added 31.48%	84,902 $213,000
Q3 2020 Nov 06, 2020	SELL	$2.39 - $3.43 $13,692 - $19,650	-5,729 Reduced 8.15%	64,573 $162,000
Q2 2020 Aug 05, 2020	BUY	$2.2 - $3.71 $44,092 - $74,355	20,042 Added 39.88%	70,302 $231,000
Q1 2020 May 12, 2020	BUY	$1.9 - $4.98 $6,490 - $17,011	3,416 Added 7.29%	50,260 $123,000
Q4 2019 Feb 05, 2020	BUY	$3.95 - $5.35 $10,811 - $14,642	2,737 Added 6.21%	46,844 $221,000
Q3 2019 Nov 13, 2019	BUY	$4.13 - $6.94 $15,553 - $26,136	3,766 Added 9.34%	44,107 $189,000
Q2 2019 Aug 12, 2019	BUY	$3.98 - $6.2 $12,039 - $18,755	3,025 Added 8.11%	40,341 $235,000
Q1 2019 May 10, 2019	SELL	$2.0 - $4.4 $296 - $651	-148 Reduced 0.4%	37,316 $144,000
Q4 2018 Feb 14, 2019	SELL	$1.61 - $3.62 $11,525 - $25,915	-7,159 Reduced 16.04%	37,464 $70,000
Q3 2018 Nov 14, 2018	BUY	$2.26 - $3.27 $12,730 - $18,419	5,633 Added 14.45%	44,623 $143,000
Q2 2018 Aug 13, 2018	SELL	$3.02 - $4.94 $8,649 - $14,148	-2,864 Reduced 6.84%	38,990 $0
Q1 2018 May 14, 2018	SELL	$3.46 - $5.14 $356 - $529	-103 Reduced 0.25%	41,854 $164,000
Q4 2017 Feb 13, 2018	BUY	$4.0 - $6.54 $86,284 - $141,074	21,571 Added 105.81%	41,957 $173,000
Q3 2017 Nov 02, 2017	BUY	$4.99 - $6.57 $101,726 - $133,936	20,386	20,386 $125,000

Others Institutions Holding TCRT

# of Institutions

Shares Held

92.6K

Call Options Held

Put Options Held

View Full List

About Alaunos Therapeutics, Inc.

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $504M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

More about TCRT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account